<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390360</url>
  </required_header>
  <id_info>
    <org_study_id>21750</org_study_id>
    <nct_id>NCT04390360</nct_id>
  </id_info>
  <brief_title>Smartphone Application for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction</brief_title>
  <acronym>Ventilo</acronym>
  <official_title>Development and Evaluation of Smartphone App for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction on Physiologic Parameter Based on the Smartphone App</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical evaluation of a new educative tools (Smartphone application) based on impact of
      instrumental dead space reduction after initiation of protective ventilation during
      mechanical ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PaCO2 Variation</measure>
    <time_frame>60 min post intervention</time_frame>
    <description>The primary outcome is to evaluate the PaCO2 variation at the end of condition 2 (after 30 minutes with protective ventilation+ HME) and condition 4 (30 minutes after Tidal volume reduction + Heater humidifier).
Variation &lt;= 10% of PaCO2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PaCO2 Variation</measure>
    <time_frame>120 min post intervention</time_frame>
    <description>The primary outcome is to evaluate the PaCO2 variation at the end of condition 2 (after 30 minutes with protective ventilation+ HME) and condition 4 (30 minutes after Tidal volume reduction + Heater humidifier).
Variation &lt;= 10% of PaCO2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between PCO2 variation and alveolar ventilation variation</measure>
    <time_frame>60 and 90 minutes post intervention</time_frame>
    <description>We will compare PaCO2 level variation and the alveolar ventilation variation to establish correlation.
Correlation variation under 10% will be significative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic impact vs pH</measure>
    <time_frame>Baseline, 30, 60, 90 and 120 minutes post intervention</time_frame>
    <description>Cardiac echographic measurement (LeftVentricularEjectionFraction) in relation with acidosis status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic impact vs pH</measure>
    <time_frame>Baseline, 30, 60, 90 and 120 minutes post intervention</time_frame>
    <description>Cardiac echographic measurement (RightVentricularEjectionFraction) in relation with acidosis status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic impact vs pH</measure>
    <time_frame>Baseline, 30, 60, 90 and 120 minutes post intervention</time_frame>
    <description>Cardiac echographic measurement Arterial pulmonary pressure) in relation with acidosis status</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>ARDS, Human</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Humidifier Lung</condition>
  <arm_group>
    <arm_group_label>Protective ventilation with HME</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Protective ventilation + HME</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protective ventilation with Heated humidifier</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Protective ventilation + HH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Implementation of protective ventilation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Protective ventilation implementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tidal Volume reduction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Tidal volume reduction</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Protective ventilation implementation</intervention_name>
    <description>In this condition, we will implement the protective ventilation related with gender and height . A blood gas will be performed at before protective ventilation implementation and at the end of this condition.Time condition 30 minutes</description>
    <arm_group_label>Implementation of protective ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Protective ventilation with HME</intervention_name>
    <description>In this condition, the patient will received protective ventilation with a Heat Moisture Exchanger (HME). A blood gas will be performed at the end of this condition.Time condition 30 minutes</description>
    <arm_group_label>Protective ventilation with HME</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Protective ventilation with Heated humidifier</intervention_name>
    <description>In this condition, the patient will received protective ventilation with a Heated humidifier. A blood gas will be performed at the end of this condition.Time condition 30 minutes</description>
    <arm_group_label>Protective ventilation with Heated humidifier</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tidal Volume reduction</intervention_name>
    <description>n this condition, we will reduce Tidal volume (with smartphone application calculation) to obtain the same alveolar ventilation (PaCO2) obtained on the HME condition</description>
    <arm_group_label>Tidal Volume reduction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old

          -  Mechanical ventilation (control,assist control or SIMV mode)

          -  haemodynamic stability (vasopressor &lt; 0.2 ug/kg/min)

          -  no prone position schedule in the next 2 hours following procedure inclusion

          -  presence of an Arterial catheter

        Exclusion Criteria:

          -  ECMO or anticipate ECMO

          -  body temperature &lt; 36.0 for post operative patient (cardiac surgery)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>François Lellouche</last_name>
    <phone>1-418-656-8711</phone>
    <email>Francois.Lellouche@criucpq.ulaval.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval</name>
      <address>
        <city>Quebec</city>
        <zip>G1V4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Alexandre Bouchard</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>2712</phone_ext>
      <email>pierre-alexandre.bouchard@criucpq.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Francois Lellouche</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 20, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

